Diphtheria Toxoid Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ( Reducing Toxin, Denatured Toxin ); Application ( Hospitals, Clinics, Ambulatory Surgical Centers )

Report Code: TIPRE00010956 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Diphtheria is a severe infection of the nose and throat that's easily preventable by a vaccine. Diphtheria toxoid is prepared by formaldehyde treatment of toxin. Toxoid is adsorbed to aluminum salts, which enhances immunogenicity. Diphtheria vaccines are based on diphtheria toxoid, a modified bacterial toxin that induces protective antitoxin antibodies of the IgG type. Toxin-producing C. diphtheriae is grown in liquid media, and the toxin converted to the inactive toxoid by treatment with formalin.

MARKET DYNAMICS

The diphtheria toxoid market is boosting the market due to the growing prevalence of chronic diseases. However, less awareness among the underdeveloped nations is likely to restraint the market growth during the forecast period. Moreover, the rise in government initiatives to enhance health care facilities, is driving the market growth in the forecast period.

MARKET SCOPE

The "Diphtheria Toxoid Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diphtheria toxoid market with detailed market segmentation by product, and application. The diphtheria toxoid market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diphtheria toxoid market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The diphtheria toxoid market is segmented on the basis of product, and application. Based on product, the market is segmented as reducing toxin and denatured toxin. On the basis of application, the market is categorized as hospitals, clinics and ambulatory surgical centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diphtheria toxoid market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diphtheria toxoid market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting diphtheria toxoid market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diphtheria toxoid market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the diphtheria toxoid market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diphtheria toxoid market are anticipated to have lucrative growth opportunities in the future with the rising demand for diphtheria toxoid in the global market. Below mentioned is the list of few companies engaged in the diphtheria toxoid market.

The report also includes the profiles of key players in diphtheria toxoid market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


    - Biocompare Inc.
    - GlaxoSmithKline plc
    - Haffkine Bio-Pharmaceutical Corporation Limited
    - List Biological Labs, Inc.
    - Medicare Pharma
    - Merck & Co., Inc.
    - Sanofi
    - Vigilomed Pharmaceuticals
    - WR International, LLC
    - Zoetis Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diphtheria Toxoid Market - By Product
1.3.2 Diphtheria Toxoid Market - By Application
1.3.3 Diphtheria Toxoid Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIPHTHERIA TOXOID MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIPHTHERIA TOXOID MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DIPHTHERIA TOXOID MARKET - GLOBAL MARKET ANALYSIS
6.1. DIPHTHERIA TOXOID - GLOBAL MARKET OVERVIEW
6.2. DIPHTHERIA TOXOID - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DIPHTHERIA TOXOID MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. REDUCING TOXIN
7.3.1. Overview
7.3.2. Reducing Toxin Market Forecast and Analysis
7.4. DENATURED TOXIN
7.4.1. Overview
7.4.2. Denatured Toxin Market Forecast and Analysis
8. DIPHTHERIA TOXOID MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers Market Forecast and Analysis
9. DIPHTHERIA TOXOID MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diphtheria Toxoid Market Overview
9.1.2 North America Diphtheria Toxoid Market Forecasts and Analysis
9.1.3 North America Diphtheria Toxoid Market Forecasts and Analysis - By Product
9.1.4 North America Diphtheria Toxoid Market Forecasts and Analysis - By Application
9.1.5 North America Diphtheria Toxoid Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diphtheria Toxoid Market
9.1.5.1.1 United States Diphtheria Toxoid Market by Product
9.1.5.1.2 United States Diphtheria Toxoid Market by Application
9.1.5.2 Canada Diphtheria Toxoid Market
9.1.5.2.1 Canada Diphtheria Toxoid Market by Product
9.1.5.2.2 Canada Diphtheria Toxoid Market by Application
9.1.5.3 Mexico Diphtheria Toxoid Market
9.1.5.3.1 Mexico Diphtheria Toxoid Market by Product
9.1.5.3.2 Mexico Diphtheria Toxoid Market by Application
9.2. EUROPE
9.2.1 Europe Diphtheria Toxoid Market Overview
9.2.2 Europe Diphtheria Toxoid Market Forecasts and Analysis
9.2.3 Europe Diphtheria Toxoid Market Forecasts and Analysis - By Product
9.2.4 Europe Diphtheria Toxoid Market Forecasts and Analysis - By Application
9.2.5 Europe Diphtheria Toxoid Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diphtheria Toxoid Market
9.2.5.1.1 Germany Diphtheria Toxoid Market by Product
9.2.5.1.2 Germany Diphtheria Toxoid Market by Application
9.2.5.2 France Diphtheria Toxoid Market
9.2.5.2.1 France Diphtheria Toxoid Market by Product
9.2.5.2.2 France Diphtheria Toxoid Market by Application
9.2.5.3 Italy Diphtheria Toxoid Market
9.2.5.3.1 Italy Diphtheria Toxoid Market by Product
9.2.5.3.2 Italy Diphtheria Toxoid Market by Application
9.2.5.4 Spain Diphtheria Toxoid Market
9.2.5.4.1 Spain Diphtheria Toxoid Market by Product
9.2.5.4.2 Spain Diphtheria Toxoid Market by Application
9.2.5.5 United Kingdom Diphtheria Toxoid Market
9.2.5.5.1 United Kingdom Diphtheria Toxoid Market by Product
9.2.5.5.2 United Kingdom Diphtheria Toxoid Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diphtheria Toxoid Market Overview
9.3.2 Asia-Pacific Diphtheria Toxoid Market Forecasts and Analysis
9.3.3 Asia-Pacific Diphtheria Toxoid Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Diphtheria Toxoid Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Diphtheria Toxoid Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diphtheria Toxoid Market
9.3.5.1.1 Australia Diphtheria Toxoid Market by Product
9.3.5.1.2 Australia Diphtheria Toxoid Market by Application
9.3.5.2 China Diphtheria Toxoid Market
9.3.5.2.1 China Diphtheria Toxoid Market by Product
9.3.5.2.2 China Diphtheria Toxoid Market by Application
9.3.5.3 India Diphtheria Toxoid Market
9.3.5.3.1 India Diphtheria Toxoid Market by Product
9.3.5.3.2 India Diphtheria Toxoid Market by Application
9.3.5.4 Japan Diphtheria Toxoid Market
9.3.5.4.1 Japan Diphtheria Toxoid Market by Product
9.3.5.4.2 Japan Diphtheria Toxoid Market by Application
9.3.5.5 South Korea Diphtheria Toxoid Market
9.3.5.5.1 South Korea Diphtheria Toxoid Market by Product
9.3.5.5.2 South Korea Diphtheria Toxoid Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diphtheria Toxoid Market Overview
9.4.2 Middle East and Africa Diphtheria Toxoid Market Forecasts and Analysis
9.4.3 Middle East and Africa Diphtheria Toxoid Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Diphtheria Toxoid Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Diphtheria Toxoid Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diphtheria Toxoid Market
9.4.5.1.1 South Africa Diphtheria Toxoid Market by Product
9.4.5.1.2 South Africa Diphtheria Toxoid Market by Application
9.4.5.2 Saudi Arabia Diphtheria Toxoid Market
9.4.5.2.1 Saudi Arabia Diphtheria Toxoid Market by Product
9.4.5.2.2 Saudi Arabia Diphtheria Toxoid Market by Application
9.4.5.3 U.A.E Diphtheria Toxoid Market
9.4.5.3.1 U.A.E Diphtheria Toxoid Market by Product
9.4.5.3.2 U.A.E Diphtheria Toxoid Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diphtheria Toxoid Market Overview
9.5.2 South and Central America Diphtheria Toxoid Market Forecasts and Analysis
9.5.3 South and Central America Diphtheria Toxoid Market Forecasts and Analysis - By Product
9.5.4 South and Central America Diphtheria Toxoid Market Forecasts and Analysis - By Application
9.5.5 South and Central America Diphtheria Toxoid Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diphtheria Toxoid Market
9.5.5.1.1 Brazil Diphtheria Toxoid Market by Product
9.5.5.1.2 Brazil Diphtheria Toxoid Market by Application
9.5.5.2 Argentina Diphtheria Toxoid Market
9.5.5.2.1 Argentina Diphtheria Toxoid Market by Product
9.5.5.2.2 Argentina Diphtheria Toxoid Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DIPHTHERIA TOXOID MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIPHTHERIA TOXOID MARKET, KEY COMPANY PROFILES
12.1. P
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Biocompare Inc.
2. GlaxoSmithKline plc
3. Haffkine Bio-Pharmaceutical Corporation Limited
4. List Biological Labs, Inc.
5. Medicare Pharma
6. Merck & Co., Inc.
7. Sanofi
8. Vigilomed Pharmaceuticals
9. WR International, LLC
10. Zoetis Inc.
TIPRE00010956
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking